Phase 1/2 first-in-human (FIH) study of CPI-0209, a novel small molecule inhibitor of enhancer of zeste homolog 2 (EZH2) in patients with advanced tumors.Nehal J. Lakhani,Martin Gutierrez, Linda R. Duska,Khanh Tu Do,Manish Sharma,Leena Gandhi,Kyriakos P. Papadopoulos, Jennifer Truong, Xiaolin Fan, Ji Hyun Lee, Suresh Bobba,Ronda Rippley,Rentian Wu, Jike Cui,Kaiming Sun,Jing Y. Wang,Patrick Trojer,Drew W. RascoJOURNAL OF CLINICAL ONCOLOGY（2021）引用 6|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
